Jump to Main Content


2020 Abstract Categories

Abstracts in the following categories will be accepted for submission for the 2020 ASH Meeting on Lymphoma Biology.

  1. Genetic Mechanisms Underlying Lymphomagenesis
    Includes genetic driven mechanisms of pathogenesis involving lymphoid malignancies and encompasses recurrent somatic mutations and/or copy number alterations as well as heritable variation associated with lymphoma risk.
  2. Epigenetics and Lymphoma
    Includes epigenetic mechanisms that underlie lymphoma pathogenesis and/or alterations to chromatic remodeling that contribute to lymphoma initiation and/or progression.
  3. RNA Metabolism & Pathogenesis
    Includes primarily basic studies of altered RNA functions in the pathogenesis of lymphoma. Includes lymphomagenic alterations in mRNA synthesis, translation and turnover, and studies of miRNAs and ncRNAs that are associated with the pathogenesis of lymphoma.
  4. Tumor Heterogeneity & Tumor Microenvironment Interactions
    Includes studies that focus on tumor clonal evolution and intra-tumoral cellular heterogeneity involving infiltrating cells in lymphoid malignancies as well as novel strategies to dynamically and non-invasively monitor such evolution. This category also includes studies investigating the role of the tumor microenvironment in tumor biology and pathogenesis.
  5. Signaling Pathways in Lymphoma
    Includes primarily basic studies of signaling pathways associated with lymphomagenesis. Includes studies of the role of post-translational receptor modification, oncogenes and tumor suppressor genes in cellular and mouse models as well as patients.
  6. Immunotherapies in Lymphoid Cancers
    Includes studies employing novel therapies that target aspects of adaptive and innate immunity as part of their mechanism of action.
  7. T-Cell Lymphomas & Rare Entities
    Includes primarily basic studies of T-cell lymphoproliferative diseases, lymphomas of infectious etiology and other rare entities.
  8. Biological & Targeted Therapies in Lymphoid Malignancies
    Includes novel targeted treatment approaches to lymphoid malignancies, including mechanism-based combination strategies.